The use of multi-species organoids as a preclinical screen to assess gastrointestinal toxicity

Epistem have validated organoid models as a screening tool to predict GI toxicity and subsequent mucosal regeneration. These assays are much quicker to perform than in vivo models and have also been shown to be highly predictive of the in vivo response.